Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control | Zendy

Valeria Mercuri | Zendy; T. D’Amico | Zendy; Denise Costa | Zendy; Corrado De Vito | Zendy; Luca D’Angelo | Zendy; Riccardo Schiaffini | Zendy; Patrizia Gargiulo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control

Author(s) -

Valeria Mercuri,

T. D’Amico,

Denise Costa,

Corrado De Vito,

Luca D’Angelo,

Riccardo Schiaffini,

Patrizia Gargiulo

Publication year - 2020

Publication title -

journal of diabetes science and technology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.039

H-Index - 75

eISSN - 1932-3107

pISSN - 1932-2968

DOI - 10.1177/1932296820949882

Subject(s) - continuous glucose monitoring , blood glucose self monitoring , medicine , acromegaly , diabetes mellitus , intensive care medicine , endocrinology , glycemic , growth hormone , hormone

Acromegaly is characterized by an insulin resistance condition. There is a significant difference between the different types of therapy in relation to the glycometabolic framework. The blinded continuous glucose monitoring system (CGMS), throughout a period of maximum 6 days for a total of 288 glycemic registrations per day, identifies glycemic excursions and could constitute a valid device to understand the 24-hour glycemic profiles.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research